# Phase 19 — SearXNG Staged Source Ingestion Closeout

**Date:** 2026-05-31
**Status:** ALL PHASES COMPLETE

---

## Phase Summary

| Phase | Status | Commit | Description |
|-------|--------|--------|-------------|
| 19A | COMPLETE | `28a65c0` | Candidate revalidation — 5 eligible |
| 19B | COMPLETE | `ab2d3a3` | 5 rows staged (ids 12–16) |
| 19C | COMPLETE | `81edae1` | Safety audit — PASS |
| 19D | COMPLETE | `3385330` | Visibility design (docs only) |
| 19E | COMPLETE | (this commit) | Closeout |

## Ingestion Results

| Metric | Value |
|--------|-------|
| Rows inserted | 5 |
| Target table | hermes_research_intelligence |
| IDs | 12, 13, 14, 15, 16 |
| Symbols | SCHD, TRX (×2), APAM, FJSCX |
| Sources | seekingalpha.com (×2), finance.yahoo.com, fool.com, zacks.com |
| All status | staged |
| Rollback SQL | docs/infra/SEARXNG_PHASE19B_STAGED_INGESTION_ROLLBACK.sql |

## Post-Ingestion State

| Metric | Value |
|--------|-------|
| hermes_research_intelligence total | 16 |
| Promoted | 10 |
| Staged | 6 (1 TELO + 5 source_discovery) |
| Embeddings | 7 (unchanged) |
| Cache sections | 10 (unchanged) |
| Audit records | 10 (unchanged) |

## Safety Summary

| Check | Result |
|-------|--------|
| DB writes | 5 rows to hermes_research_intelligence (staging only) |
| Production writes | ZERO |
| Embeddings | ZERO |
| Promotions | ZERO |
| Hermes autonomous integration | NO |
| Public exposure | NO |
| External APIs | ZERO |
| Broker access | NONE |
| Proposal/trade/journal mutations | ZERO |
| Secrets committed | ZERO |
| SearXNG binding | 127.0.0.1 (unchanged) |
| Command Center changes | NONE (existing page shows new rows) |
| Rollback readiness | YES |
| Unrelated archive renames | NO |

## Recommended Next Gates

| Option | Description |
|--------|-------------|
| A | Observation period |
| B | Phase 20 — Hermes Agent Operating Model and Registry |
| C | Dashboard visibility for staged SearXNG source candidates |
| D | Embedding pilot for staged source candidates, max 2, separate approval |

NOT recommended yet:
- Autonomous external research
- Auto-ingestion
- Public exposure / Tailscale
